Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRUCIAL neonatal allopurinol trial in critical congenital heart disease
2024-513041-37-00Phase 3Suspended
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cardiovascular Malformation (CVM) and traumatic brain injury (TBI) comparing ACEPURIN with Placebo Mannitol (2 arms). Primary endpoint: Composite brain injury or instability for MRI or mortality. Started Feb 2020; status: suspended.
02
Drugs
allopurinol
03
Conditions
Cardiovascular Malformation (CVM)traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2024-513041-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513041-37-00.